Epoprostenol Injection, Powder, Lyophilized, For Solution
Product Images NDC 67457-587

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Epoprostenol (NDC 67457-587). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Mylan Institutional Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Epoprostenol For Injection 0.5 mg Carton Label (Image 01)

This is a description of a pharmaceutical product containing Epoprostenol for injection. The product includes sucrose, arginine, and sodium hydroxide to adjust pH. The storage instructions recommend keeping the lyophilized product at 20°C and protecting it from light. The full prescribing information includes details on dilution, storage, and stability of solutions. It is a sterile, single-dose vial intended for controlled room temperature storage.*

FDA Label Image

Epoprostenol For Injection 1.5 mg Carton Label (Image 02)

The text provides information on a medication called Epoprostenol for Injection, which is contained in vials with specific quantities of epoprostenol sodium, sucrose, arginine, and sodium hydroxide to adjust pH. The usual dosage is 1.5 mg per vial. It is recommended to store the lyophilized product at 20°C. The product is indicated for intravenous use and is sterile. The text also mentions specific storage instructions, including room temperature stability, and provides contact information for the manufacturer. The text suggests that the product is produced in India.*

FDA Label Image

Infusion Rate Formula (Image 03)

This text provides a formula for calculating the infusion rate in mL/hr based on the final concentration in ng/mL. It involves multiplying the dose in ng/kg/min by the weight in kg and then dividing by 60 to get the infusion rate in mL/hr equal to the final concentration in ng/mL.*

FDA Label Image

Epoprostenol Structural Formula (Image 04)

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.